Shots: Lupin in collaboration with Aptar Pharma launch ADHERO, a smart device designed to help patients with chronic respiratory diseases by tracking MDI usage thus facilitate adherence to the therapy The launch will help patients utilizing MDI and HCPs to track adherence and compliance to therapy via patient’s dashboard as well as the app, thus […]Read More
Tags : Respiratory Diseases
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US